Novel Immunotherapy Selectively Targets Malignant T Cells

One major hurdle in the development of safe and effective immunotherapies has been the risk of depleting healthy T cells during CAR-T treatment that seeks out a

Related Keywords

Juliam Lewis ,Kacier Carlson ,Francine Foss ,Jingjing Ren ,Jungsoo Chang ,Xiaofeng Liao ,Michael Girardi ,Rs Evans Foundation ,Nature Communications ,Yale Cancer Center ,Evans Professor ,Yale School ,Yale Cancer ,Newswise ,Mmunotherapy Malignantt Cells Healthy ,All Journal News ,Cell Biology ,Mmunology ,Ature Journal ,Cancer Center Featured Story 2 ,Yale Cancer Center Smilow Hospital ,